Public Profile

Nippon Shinyaku Co

Nippon Shinyaku Co., Ltd., commonly referred to as Nippon Shinyaku, is a prominent pharmaceutical company headquartered in Japan. Established in 1923, the company has made significant strides in the healthcare sector, focusing on the development and manufacturing of innovative pharmaceuticals and medical devices. With a strong presence in both domestic and international markets, Nippon Shinyaku operates extensively across Asia, Europe, and North America. The company is renowned for its core products, which include prescription medications, particularly in the fields of oncology, urology, and orthopaedics. Nippon Shinyaku's commitment to research and development has positioned it as a leader in the pharmaceutical industry, with notable achievements in drug discovery and a robust pipeline of new therapies. Through its dedication to improving patient outcomes, Nippon Shinyaku continues to enhance its market position as a trusted provider of high-quality healthcare solutions.

DitchCarbon Score

How does Nippon Shinyaku Co's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

38

Industry Average

Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

22

Industry Benchmark

Nippon Shinyaku Co's score of 38 is higher than 92% of the industry. This can give you a sense of how well the company is doing compared to its peers.

92%

Nippon Shinyaku Co's reported carbon emissions

In 2023, Nippon Shinyaku Co., headquartered in Japan, reported total greenhouse gas emissions of approximately 18,883,000 kg CO2e. This figure includes 4,366,000 kg CO2e from Scope 1 emissions, 4,057,000 kg CO2e from Scope 2 emissions, and a significant 188,834,000 kg CO2e from Scope 3 emissions, which primarily arise from purchased goods and services. Nippon Shinyaku has set ambitious climate commitments, aiming to reduce its absolute Scope 1 and 2 greenhouse gas emissions by 42% by FY2030, using FY2020 as the baseline. Additionally, the company targets a 25% reduction in absolute Scope 3 emissions from purchased goods and services within the same timeframe. These targets align with the Science Based Targets initiative (SBTi) and are designed to contribute to limiting global warming to 1.5°C. The company's emissions data reflects a proactive approach to sustainability within the pharmaceuticals, biotechnology, and life sciences sector, demonstrating a commitment to reducing its carbon footprint and addressing climate change effectively.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20132014201520162017201820192020202120222023
Scope 1
428,000
0,000,000
0,000,000
0,000,000
0,000,000
0,000,000
0,000,000
0,000,000
0,000,000
0,000,000
0,000,000
Scope 2
-
0,000,000
0,000,000
0,000,000
0,000,000
0,000,000
0,000,000
0,000,000
0,000,000
0,000,000
0,000,000
Scope 3
-
00,000
0,000,000
0,000,000
0,000,000
0,000,000
0,000,000
0,000,000
0,000,000
0,000,000
000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Nippon Shinyaku Co's primary industry is Medical, precision and optical instruments, watches and clocks (33), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Nippon Shinyaku Co is headquartered in JP, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Nippon Shinyaku Co is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Similar Organizations

Sarepta Therapeutics

US
Chemicals nec
Updated 5 days ago

Biogen

US
Research and development services (73)
Updated 5 days ago

Sanofi

FR
Chemicals nec
Updated about 5 hours ago

PYC Therapeutics Limited

AU
Health and social work services (85)
Updated about 4 hours ago

Ionis Pharmaceuticals

US
Medical, precision and optical instruments, watches and clocks (33)
Updated 5 days ago

Takeda

JP
Medical, precision and optical instruments, watches and clocks (33)
Updated about 13 hours ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers